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Abstract 
Neuronal type nicotinic acetylcholine receptors (nAchRs) have recently been identified in small-cell ung carcinoma. We here show that both 
nicotine and cytisine stimulate [3H]serotonin release in a dose-dependent manner; this effect is antagonized by a-bungarotoxin (aBgtx) and 
a-conotoxin MI (czctx). Nicotine and cytisine stimulate in vitro SCLC proliferation and this effect is completely antagonized by both aBgtx and aCtx. 
By PCR analysis, we demonstrate the presence in SCLC of both the a, and the & nAchR subunits mRNA. These data show that nAchRs play an 
important role in the biology of SCLC, and that algtx-sensitive receptors of the a7 subtype are crucially involved in both the secretagogue and 
mitogenic effects of nicotinic agonists. 
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1. Introduction nicotine is important for understanding its mitogenic ef- 
fects. 
Until recently, small cell lung carcinoma (SCLC) cells We now report that SCLC cells express the a7 nicotinic 
have been though to express only cholinergic receptors subunit mRNA, which codes for the major aBgtx-bind- 
of the muscarinic type [ 11. In the last few years, however, ing nicotinic subunit in the nervous system, and that both 
cholinergic nicotinic receptors have also been described clBgtx and aCtx block the secretagogue and mitogenic 
in these cells [2-51. effects of nicotine. 
Most interestingly, SCLC nicotinic receptors have 
been shown to be of neuronal type [3,4]: in particular, 
SCLC cells express 01, and fi4 neuronal nicotinic receptor 
subunits, charbacol-sensitive [3H]TPMP binding sites [4] 
and aBgtx binding sites with neuronal characteristics. 
These aBgtx binding sites are not recognized by a mon- 
oclonal antibody (mAb35) recognizing muscle type nico- 
tinic receptors, and, furthermore, SCLC cells do not ex- 
press the a, muscle type aBgtx-binding subunit [3] . 
These results represent the first demonstration of a 
physiological role of aBgtx-sensitive, neuronal type nico- 
tinic receptors in lung cancer, and might help in elucidat- 
ing its role in the nervous system as well. 
2. Materials and methods 
2.1. Cell lines 
Nicotine is known to be mitogenic for several types of 
lung tumors [5-81, including SCLC [2,8]. We have re- 
cently shown that nicotine is also a potent secretagogue 
for SCLC cells, stimulating the release of substances, 
such as serotonin, that, in turn, act as potent mitogens 
[8]. Therefore, determining the mechanisms and the sub- 
types of receptors involved in the secretagogue effects of 
Human SCLC cell lines (GLC8, NCI-N592 and NCI-H-69) were 
kindly provided by Prof. G. Gaudino (Dept. of Biomedical Sciences and 
Oncology, Turin, Italy). They were grown in suspension in RPM1 1640 
medium supplemented with 10% fetal calf serum, 100 IU/ml penicillin, 
100 mg/ml streptomycin in IO-cm diameter Falcon tissue culture dishes. 
Cells were incubated at 37°C in a humidified atmosphere of 10% CO2 
in air. 
2.2. [‘H]Serotonin release 
SCLC cells were recovered from the dishes and passed three times 
through a sterile syringe in order to dissociate the cell clusters. After 
centrifugation (5 min, 800 rpm), the cells were resuspended ina Krebs- 
Ringer-HEPES (KRH) solution containing (in mM) 150 NaCl, 5 KCl, 
1.2 MgS04 and KH,PO,, 2 CaCl,, 6 glucose and 25 HEPES-NaOH @H 
7.4). The medium also contained equal amounts (0.1 mg/ml) of ascorbic 
acid (Merk) and of the monoamine oxidase inhibitor pargyline (Sigma), 
plus [3H]5HT (specific activity 11.6 Ci/mmol; final concentration 500 
nM, Amersham). After 30 min at 37”C, the cells were centrifuged 
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(5 min, 800 rpm), resuspended in KRH containing the 5HT reuptake 
inhibitor ~l-I~pr~ne (1 PM, RBI), and aliquoted in Eppendorf 
tubes containing the desidered rug concentration. To assay the block 
potency of nAchR antagonists on [3H]5HT release, the cells were prein- 
cubated with drugs and toxins 30 min before, and during the stimula- 
tion period at 37°C. At the end of stimulation with agonists, carried 
out for 5 min (or different periods of time, in the case of the time course 
acquisition) at 37”C, the cells were washed three time with ice-cold 
butler. Finally the pellets were counted to determine the amount of 
13H15HT left over. Samnles. dissolved in 300 ul of NaOH 1 mM and 
then in 5 ml of Atomhght’(Du Font), were ‘counted in a j? counter 
(Beckman Instruments, model LS7500) with an efficency of 40%. The 
amount of release is expressed as percent increase over basal. 
All solution salts were purchased from Merk, nicotine and cytisine 
were obtained from Sigma, a- and KBgtx from Biotoxins, aCtx MI from 
RBI. 
2.3. r3~~~~yrn~dine incorporation 
SCLC cells were plated in RPM1 1640 in 96-well microtiter plates at 
a density of 2-5 x lo3 cells/well. Cells were preincubated for 15’ before 
the addition of nicotine, cytisine or serotonin, and then incubated for 
48 hrs at 37°C in a hawed atmosphere of 10% CO, in air. 
Methyi[3~~id~e (1 @iiwell; specific activity 2 Cilmmol, Amer- 
sham) was added during the last six hours of incubation. At the end of 
the incubation period, cells were washed and lysed with distilled water 
and collected on filters with an automatic ell harvester (Titertek, Flow 
Laboratories). The filters were placed in Filter Count Scintillation fluid 
(Packard), and counted using standard procedures. 
2.4. PCR analysis 
First-strand cDNA was synthesized from 200 ng of Poly(A)’ RNA 
using the first-strand cDNA synthesis kit (Stratagene) and the supplied 
random examer primers. 5% of the cDNA synthesized was amplified 
using Taq polimerase (Promega). 25 amplification cycles (95°C for 1’; 
56°C for 1’; 72°C for 1’) were performed in the presence of specific 
mimers folIowing Promeaa urocedure. RT-PCR amnlification nrod- - . 1 
ucts were analysed by Southern blot with specific 32P-labelled ofigonu- 
cleotides as previously indicated [9]. Primers and oligonucleotidic 
probes, drawn on the published sequences, were as follows: 5’43s: 
CGA CAT CAA GTA CAA CT, C-a,: AAG ACT GTA l-l-C T-l-A 
A; 3’-a,AS: TAG AGC TTC TCG TGA GG; 5’-B,S: GCC TGC GCC 
TGC GGC GAC GCC; C;s,: GCC CCA GGG GCC GAC TCC TGC 
ACG TGC ‘FTC GTC AAC CG; 3’-B,-AS: CCT CAC TCA CGC TCT 
GGT CAT; S-US: CCA CCA ACA ‘MT GGC TAC AAA TC; C-a,: 
CAA GAG TTC CTG CTA CAT CGA TG; 3’a,-AS: ATG GTC ACT 
GTG AAG GTG ACA TC; 5’~j$,S: CAA CAA CCT GAT CCG CCC 
AGC: C-p4 GTA GAG AGA CA& CTC ATA GGT; ?‘-B,AS: GAA 
GGG AAA GTA CTT CAC CTC. 
3. Results and discussion 
3. f . ~~cotinic agonists induce ~3~~se~oton~~ release from 
SCLC cells 
One of the effects of nicotinic receptor stimulation in 
the nervous system is the induction of neurotrans~tter 
release [IO]. We have recently shown that nicotine stimu- 
lates E3H]5HT release from SCLC cells, a process strictly 
related to cell proliferation [S]. This effect was found to 
be dependent on extracellular Ca2’ and blocked by the 
ganglionic nicotinic antagonist mecamylamine [8]. 
We have now extended this functional analysis of 
SCLC nAchRs. Maximal nicotine-induced [3H]5HT re- 
lease from GLC8 SCLC cells is achieved after 5 min at 
37°C (Fig. 1, inset) and for all further experiments we 
adopted this protocol of stimulation. Both nicotine and 
cytisine, a selective neuronal nicotinic receptor agonist, 
were found to be effective secretagogues for SCLC cells 
(Fig. 1). Both nicotine and cytisine effects were dose- 
dependent (Fig. 1) with nicotine being two orders of 
magnitude more potent than cytisine (EC& of 27 pM and 
1 nM for nicotine and cytisine, respectively). 
Nicotine (100 nM) stimulated a similar amount of 
rH]SHT release from the three different SCLC cell lines 
tested, all of them known to express neuronal-type nico- 
tinic receptors [3,4], the maximal release detectable with 
100 nM nicotine (22.5 * 1, 20 + 2 and 23.5 f 0.7% in 
NCI-N-592, NCI-H-69 and GLC8 cells, respectively) 
being comparable, in each cell line, to that obtained with 
a maximal effective concentration of 60 mM KC1 
(24 + 3,21 rt 2 and 28 f 1.5% in NCI-N-592, NCI-H-69 
and GLC8 cells, respectively). 
3.2. Block of ~3~~serotonin release by ~g~~garatoxi~ 
and related toxins 
Nicotine-induced [‘H].5HT release was inhibited in a 
dose-dependent manner by the two related nicotinic an- 
tagonists, clBgtx and oCtx (Fig. 2), with IC,,s of 1 nM 
and 10 pM, respectively. Also cytisine-indu~d (1 ,uM) 
[3H]5HT release was efficiently antagonized by the two 
different cx toxins (61 2 2% and 60 rt 9% of inhibition at 
625 nM clBgtx and 863 aCtx, respectively, n = 3). 
aBgtx binding sites have been previously described in 
SCLC [l-3], but their functional role was not investi- 
gated. We here show, for the first time, that EBgtx-sensi- 
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Fig. 1. Doseresponse curve of nicotine- and cuisine-ind~ [“H]SHT 
release from GLCI SCLC cells. Nicotine (0) and cytisine (0) both 
stimulate [HISHT release in a dose-dependent manner, but their efi- 
cacy is different, nicotine being more than one order of magnitude more 
potent than cytisine. Their ECSo were 27 pM and 1 nM for nicotine and 
cytisine, respectively. Furthermore, nicotine has the same effect in NCI- 
H69 and NCI-N592 cell lines (see text). Data are expressed as percent- 
age increases over basal release. Each point represents the aver- 
age rt: SE. of S-8 experiments performed in quadruplicate as described. 
Inset: Time-course of nicotine-induced rH]-5HT release in GLCI cells. 
We performed rH]-5HT release experiments with different periods of 
stimulation: 30”, l’, 3’, 5’, lo’, and found that maximal secretion is 
achieved after 5’. We adopted this period for all subsequent experi- 
ments. Data are expressed as described. 
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Fig. 2. Effect of nAchR toxins on nicotine-stimulated [‘H]SHT release. 
aBgtx (e) and c&x MI (m) both inhibit nicotine-stimulated [‘H]5HT 
release in a dose-de~ndent manner with I&, values of I nM and 10 
pM, respectively. The maximal inhibition obtained was similar, varying 
from 88% with aBgtx to 83% with czCtx MI. Each point represents the 
average + SE. of 46 experiments performed in quadruplicate as de- 
scribed. 
tive nicotinic receptors play a crucial role in SCLC cells, 
inhibiting nicotine-induced rHJ5HT release. It is known 
that neuronal type aBgtx receptors represent functional 
ion channels, and that they are highly permeable to Ca2+ 
[l l-131; however their role in cellular processes is still 
largely unknown. We here show that neuronal-ty~ 
aBgtx receptors mediate the secretagogue effects of nico- 
tine in SCLC. It is tempting to speculate that they might 
play the same role in other neurosecretory cells and in 
the nervous system as well. 
aCtx was as efficaceous as, and even more potent than 
clBgtx in inhibiting 13H]5HT release (Fig. 2). This toxin 
is a potent antagonist of the crBgtx-sensitive muscular 
nAchRs [14], but did not block the neuronal nAchRs 
studied so far [15]. 
To our knowledge this is the first evidence that olCtx 
blocks a neuronal-type nAchR subtype, i.e. the aBgtx- 
sensitive one, suggesting a conserved binding site struc- 
ture for both toxins in muscle and neuronal aBgtx-sensi- 
tive receptors. Therefore aCtx might become an impor- 
tant tool, together with aBgtx, for studying both SCLC 
and neuronal nicotinic receptor subtypes. 
~Bungarotoxin~ a less selective polypeptide nicotinic 
antagonist [IQ also inhibited potently and dose-depen- 
dently nicotinic-induced [3H]5HT release (IC, I PM). At 
700 nM, lcBgtx was as efficaceous as clBgtx and clCtx in 
inhibiting either 100 nM nicotine-(80 ? 4% of inhibition 
or 1 PM cytisine-(65 + 3 of inhibition) [3H]5HT release. 
[‘251]~Bgt~ binds with high affinity and specificity to 
both NCI-H-69, NCI-N-592 and GLCS SCLC cell lines 
(E. Sher et al., unpublished results). As in neurons, ‘*‘I- 
KBgtx probably binds to heterogeneous nAchR subtypes 
in SCLC cells, since its binding is mostly, although not 
completely inhibited by either aBgtx, or crCtx. Therefore, 
while most binding sites are shared by the a and the K 
toxins in SCLC cells, a small amount of aBgtx and clCtx 
insensitive nicotinic receptors are probably present. Fur- 
ther work will elucidate if they play any specific role in 
hormone secretion. 
3.3. Nicatinic receptors and SCK’ proliferation 
We have recently shown that serotonin is a potent 
mitogen for SCLC cells and that nicotine-induced release 
of serotonin from SCLC is probably one of the main 
mechanisms mediating nicotine stimulation of SCLC 
growth [5]. Indeed, both nicotine-stimulated serotonin 
release and nicotine-stimulated cell proliferation were 
blocked by the ganglionic nicotinic antagonist mecam- 
ylamine. 
The finding that also aBgtx and olCtx are potent 
antagonists of nicotine-indu~d serotonin release, 
prompted us to evaluate if these toxins were also able to 
inhibit nicotine-induced SCLC proliferation. 
We have found that both clBgtx and aCtx (both at 1 
PM) completely antagonized nicotine and cytisine stimu- 
lation of SCLC proliferation (Fig. 3) without affecting 
NCI-II-69 n_ii,m 1 
Nicotine 100 nM +++ -._ -__ 
Cytisine 10 pM - - - ++* --- 
Scroumio 1 )rM - - - - - - +++ 
nBgtxiS3pM * + - - + - - + - 
nCtx l.lwM - - + - - + - - + 
Fig. 3. Effect of ccBgtx and &Ctx on SCLC proliferation. Both nicotine- 
and cytisine-induced increases of cell proliferation were blocked by the 
two nicotinic a-toxins aBgtx and aCtx at maximal doses, while no effect 
is detectable with the serotonin-simulated cell proliferation. Similar 
results were obtained in three different cell lines: GLCS, NC&N592 and 
NCI-H-69. Values are expressed as percentage increases over basal. 
Bars represent he average f SE. of 3 experiments, each performed in 
quadruplicate 
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Fig. 4. RT-PCR analysis for transcripts encoding nicotinic receptor 
subunits in human neuroblastoma (SH-SKNBE) and small cell lung 
carcinoma (GLCI) cell lines. a3, a,, /?2 and /14 amplification products 
from SH-SKNBE and GLCI cells were analysed by Southern blot with 
specific oligonucleotidic probes. RT-PCR products of a,, ar, /$ and /I4 
are present in both cell lines. Control reactions, without reverse tran- 
scriptase, remained negative. 
serotonin-stimulated cell proliferation, extending our 
previous findings indicating that neuronal nicotinic re- 
ceptors mediate the biological effects of nicotine on 
SCLC cells. We suggest that nicotinic control of both 
hormone release and cell proliferation is carried out by 
the neuronal-type aBgtx receptor present in SCLC cells. 
3.4. Different a and p nicotinic subunit mRNA are 
expressed in SCLC cells 
We previously demonstrated the presence of both a, 
[4] and a, [3] nicotinic subunits in SCLC cells and the 
absence of a1 [3]; the pharmacological and functional 
data here reported confirm that SCLC nAchRs are heter- 
ogeneous molecular entities. 
However, besides some suggestions that a, does bind 
aBgtx under particular conditions [3,17], no clearcut ev- 
idence for aBgtx binding subunits in SCLC was yet 
avalaible. We here show that mRNA for a,, the domi- 
nant and most diffuse aBgtx binding subunit of the nerv- 
ous system, is expressed in SCLC cells (Fig. 4) suggest- 
ing that also in these cells it might represent he most 
important aBgtx binding subunit. We also found that 
SCLC express both p2 and /I4 subunits (Fig. 4): interest- 
ingly p4 is supposed to confer cytisine sensitivity to neu- 
ronal nAchRs, while & is supposed to confer lcBgtx sen- 
sitivity [15-181. 
The functional and molecular findings that we have 
here reported suggest hat the aBgtx-sensitive nicotinic 
receptor mediating nicotinic agonist-induced hormone 
secretion and cell proliferation is of the a, subtype. This 
a, nAchR is highly permeable to Ca*’ [l l-l 31 and cal- 
cium influx is necessary for both hormone secretion and 
cell proliferation. Ca*’ ions might indeed enter the cells 
both through the nicotinic channel itself and through the 
voltage-dependent Ca*’ channels which will open in re- 
sponse to the nicotinic-induced cell depolarization. 
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Which of the two pathways is more relevant to the con- 
trol of secretion still has to be investigated. We have also 
shown that FcBgtx specific receptors, although present, 
play a minor role in nicotinic agonist-induced [3H]5HT 
secretion. Furthermore, mRNA for both /I2 and /I4 sub- 
units are expressed in SCLC cells. These data, together 
with previous reports [2-4], confirm the heterogeneity of 
nAchRs in SCLC cells, and suggest hat besides the a7 
subtype, other neuronal type nAchRs might have a spe- 
cific, still undefined, role in the biology of SCLC. 
Finally, our findings further confirm that, although of 
epithelial origin, SCLC cells have much in common with 
neurons. Voltage-operated calcium channel subtypes 
previously believed to be expressed only in neurons (N 
and P types) have recently been shown to be present, and 
involved in the control of hormone release from SCLC 
[ 19,201. The neuronal type nicotinic receptors represent 
another family of ‘neuronal’ ion channels expressed by 
SCLC cells. 
All these different membrane ion channels, both volt- 
age and agonist-operated, so important in the control of 
hormone release from SCLC cells, might well become 
selective targets for new pharmacological approaches to 
the treatment of this very aggressive human cancer. 
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